PharmaCan announced that it has implemented a change to its Board of Directors reducing the number of serving Board members from seven to five. Mr. Ari Huber and Mr. Steven Isenberg have tendered their resignations and have stepped down from the board. Mr. Huber will continue to serve the company in his ongoing role of Chief Financial Officer.